Inhibition of radiographic progression in psoriatic arthritis by adalimumab independent of the control of clinical disease activity

OBJECTIVES: To evaluate the relationship between radiographic progression and disease activity in subjects with PsA treated with adalimumab (ADA) or placebo (PBO) and the impact of concomitant MTX. METHODS: This was a post hoc analysis of the randomized, double-blind, PBO-controlled ADEPT trial. Sub...

Descripción completa

Detalles Bibliográficos
Autores principales: Landewé, Robert, Ritchlin, Christopher T, Aletaha, Daniel, Zhang, Ying, Ganz, Fabiana, Hojnik, Maja, Coates, Laura C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532443/
https://www.ncbi.nlm.nih.gov/pubmed/30608620
http://dx.doi.org/10.1093/rheumatology/key417

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532443/
https://www.ncbi.nlm.nih.gov/pubmed/30608620
http://dx.doi.org/10.1093/rheumatology/key417

Ejemplares similares